Algo version: 0.98b
Gilead Sciences Inc is listed at the XETRA Exchange
Gilead Sciences Inc [GIS.DE]
XETRA Sector: Biotechnology Industry:Drug Manufacturers—General

Is Gilead Sciences Inc stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Gilead Sciences Inc pays dividends. Last time was Friday 27th of September 2024 where the investors holding the stock on Friday 13th of September 2024 were paid €0.69319 per share. Over the last 38 times between 2015 and 2024, Gilead Sciences Inc has paid €23.72319 with an average of €0.62 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Gilead Sciences Inc 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was €59.10, you would have made a profit of €11.87 per share or 20.08%

No, the average daily trading liquidity for Gilead Sciences Inc is €1 767 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Gilead Sciences Inc has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.34, the company's ability to pay off the debt is normal. The company has a very low net profit margin of 1.76%, which is challenging.

We have calculated the inflation risk for Gilead Sciences Inc to be low [0.5 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.